Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals

A comprehensive overview of medical AI devices approved by the US Food and Drug Administration sheds new light on limitations of the evaluation process that can mask vulnerabilities of devices when they are deployed on patients.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Breakdown of 130 FDA-approved medical AI devices by body area.

References

  1. Liu, X. et al. Nat. Med. 26, 1364–1374 (2020).

    Article  CAS  Google Scholar 

  2. Norgeot, B. et al. Nat. Med. 26, 1320–1324 (2020).

    Article  CAS  Google Scholar 

  3. Cruz Rivera, S., Liu, X. & Chan, A. W. et al. Nat. Med. 26, 1351–1363 (2020).

    Article  CAS  Google Scholar 

  4. U.S. Food & Drug Administration Center for Devices and Radiological Health. https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm514737.pdf (October 2017).

  5. U.S. Food & Drug Administration Center for Devices and Radiological Health. https://www.fda.gov/media/145022/download (January 2021).

  6. U.S. Food & Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/denovo.cfm (accessed 14 December 2020).

  7. U.S. Food & Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm (accessed 14 December 2020).

  8. U.S. Food & Drug Administration. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm (accessed 14 December 2020).

  9. Benjamens, S., Dhunnoo, P. & Meskó, B. Npj Digit. Med. 3, 1–8 (2020).

    Article  Google Scholar 

  10. American College of Radiology. https://www.acrdsi.org/DSI-Services/FDA-Cleared-AI-Algorithms (accessed 29 November 2020).

  11. Kaushal, A., Altman, R. & Langlotz, C. J. Am. Med. Assoc. 324, 1212–1213 (2020).

    Article  Google Scholar 

  12. Wang, X. et al. 2017 IEEE Conference on Computer Vision and Pattern Recognition 3462–3471 (Institute of Electrical and Electronics Engineers, 2017).

  13. Irvin, J. et al. The Thirty-Third AAAI Conference on Artificial Intelligence 590–597 (Association for the Advancement of Artificial Intelligence, 2019).

  14. Johnson, A. E. W. et al. Sci. Data 6, 317 (2019).

    Article  Google Scholar 

  15. Huang, G., Liu, Z., Van Der Maaten, L. & Weinberger, K.Q. 2017 IEEE Conference on Computer Vision and Pattern Recognition 4700–4708 (Institute of Electrical and Electronics Engineers, 2017).

  16. Seyyed-Kalantari, L., Liu, G., McDermott, M., Chen, I. Y. & Ghassemi, M. Pac. Symp. Biocomput. 26, 232–243 (2021).

    PubMed  Google Scholar 

  17. U.S. Food & Drug Administration. https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/postmarket-requirements-devices (2018).

  18. Ferryman, K. J. Am. Med. Inform. Assoc. 27, 2016–2019 (2020).

    Article  Google Scholar 

Download references

Acknowledgements

J.Z. is supported by the National Science Foundation (CCF 1763191 and CAREER 1942926), the US National Institutes of Health (P30AG059307 and U01MH098953) and grants from the Silicon Valley Foundation and the Chan-Zuckerberg Initiative. R.D. is supported by the US National Institutes of Health (T32 5T32AR007422-38). Our compiled database of approved medical AI devices, analysis code, and models used for the case study are all available at https://ericwu09.github.io/medical-ai-evaluation.

Author information

Authors and Affiliations

Authors

Contributions

E.W., K.W. and J.Z. designed the study. E.W., K.W. conducted research with help from R.D. and D.O. All the authors contributed to interpretation of the results and writing of the manuscript.

Corresponding author

Correspondence to James Zou.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, E., Wu, K., Daneshjou, R. et al. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat Med 27, 582–584 (2021). https://doi.org/10.1038/s41591-021-01312-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-021-01312-x

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing